Aperio Group’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$1.14M Buy
49,436
+585
+1% +$13.5K ﹤0.01% 1527
2020
Q3
$690K Buy
48,851
+2,187
+5% +$30.9K ﹤0.01% 1636
2020
Q2
$704K Buy
46,664
+5,138
+12% +$77.5K ﹤0.01% 1590
2020
Q1
$384K Sell
41,526
-11,221
-21% -$104K ﹤0.01% 1785
2019
Q4
$514K Buy
52,747
+26,596
+102% +$259K ﹤0.01% 1783
2019
Q3
$210K Buy
26,151
+389
+2% +$3.12K ﹤0.01% 2155
2019
Q2
$322K Buy
25,762
+4,026
+19% +$50.3K ﹤0.01% 1992
2019
Q1
$296K Buy
21,736
+1,525
+8% +$20.8K ﹤0.01% 2003
2018
Q4
$194K Buy
20,211
+3,534
+21% +$33.9K ﹤0.01% 2134
2018
Q3
$202K Buy
16,677
+1,323
+9% +$16K ﹤0.01% 2187
2018
Q2
$240K Sell
15,354
-396
-3% -$6.19K ﹤0.01% 2092
2018
Q1
$237K Buy
15,750
+77
+0.5% +$1.16K ﹤0.01% 2063
2017
Q4
$226K Buy
15,673
+347
+2% +$5K ﹤0.01% 2096
2017
Q3
$231K Buy
15,326
+1,340
+10% +$20.2K ﹤0.01% 2058
2017
Q2
$141K Buy
13,986
+1,663
+13% +$16.8K ﹤0.01% 2149
2017
Q1
$88K Buy
+12,323
New +$88K ﹤0.01% 2116